miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma.

导出 OA

翻译打印收藏纠错

作者： Nanmu,Yang ^[1] ; Jinxue,Zhou ^[2] ; Qingjun,Li ^[3] ; Feng,Han ^[2] ; Zujiang,Yu ^[3]

作者单位： 1Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450052 Henan China. ^[1] 2Department of Hepatopancreatobiliary Surgery, Henan Cancer Hospital, No. 127, Dongming Road, Zhengzhou, 450008 Henan China. ^[2] 3Department of Hepatopancreatobiliary Surgery, The Affiliated Tumor Hospital of Zhengzhou University, No. 127, Dongming Road, Zhengzhou, 450008 Henan China. ^[3]

关键词 AKT/GSK-3β/β-catenin FOXO1 HepG2 cells Proliferation miR-96

DOI 10.1186/s12935-019-0756-7

PMID 30828264

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览10

Cancer cell international

2019年19卷

38页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma.

Cancer cell international

相似文献

Cancer cell international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma.

Cancer cell international

相似文献

Cancer cell international

相关期刊

检索历史清除